NCL Guideline for the treatment of Chronic Spontaneous Urticaria in ...
[Pages:14]North Central London Joint Formulary Committee
Guideline for the treatment of Chronic Spontaneous Urticaria in adult patients
Disclaimer
This guideline is registered at North Central London (NCL) Joint Formulary Committee (JFC) and is intended solely for use by healthcare professionals to aid the treatment of patients within NCL. However, clinical guidelines are for guidance only, their interpretation and application remain the responsibility of the individual clinician. If in doubt, contact a senior colleague or expert. Clinicians are advised to refer to the manufacturer's current prescribing information before treating individual patients.
The authors and NCL JFC accept no liability for use of this information from this beyond its intended use.
While we have tried to compile accurate information in this guideline, and to keep it updated in a timely manner, we cannot guarantee that it is fully complete and correct at all times. If you identify information within this guideline that is inaccurate, please report this to the admin.ncl-mon@. If a patient is harmed as a consequence of following this guideline, please complete a local incident report and inform admin.ncl-mon@.
This guideline should not be used or reproduced for commercial or marketing purposes.
NCL JFC is funded by and provides advice to Acute Trusts and Clinical Commissioning Groups in NCL.
North Central London Joint Formulary Committee Guidelines for the treatment of Chronic Spontaneous Urticaria in adult patients Version 1.0
1 of 14 Approval date: 17/02/2020
Review date: 17/02/2023
Document control
Date
Version Amendments
17/02/2020 V1.0 New document
Groups / Individuals who have overseen the development of this guidance:
M Radcliffe ? Consultant Allergologist (UCLH) G Grewal ? Pharmacist (NCL JFC) M Dziadzio ? Consultant Immunologist (UCLH) R Dixon ? General Practitioner (Islington CCG) N Patel ? Pharmacist (Camden CCG)
Groups which were consulted and have given approval:
W Bakkour ? Consultant Dermatologist (UCLH) S Berkovitz ? Consultant, General Medicine (UCLH) M Buckland ? Consultant Immunologist (RFL)
File name:
Guidelines for the treatment of Chronic Spontaneous Urticaria in adult patients
Version number:
1.0
Available on:
ncl-mon.nhs.uk
Disseminated to:
NCL Provider Trusts and CCGs
Equality impact assessment:
Patients ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- all that cavalier owners need to know about the reverse sneeze or
- swallowing snorting ohrn
- 20 641s007 loratadine clinical pharmacology biopharmaceutics review
- loratadine usp micronized medisca
- ncl guideline for the treatment of chronic spontaneous urticaria in
- loratadine first medipharma
- product information claritin brand of loratadine tablets syrup and
- safety data sheet page 1 of 5 loratadine revision cayman chem
- design and development of quick dissolving tablet containing loratadine
- klonopin high from snorting
Related searches
- treatment of chronic pain syndrome
- reasons for the fall of rome
- 10 reasons for the fall of rome
- for the purposes of definition
- twenty arguments for the existence of god
- word for the origin of words
- formulas for the laws of motion
- reason for the fall of rome
- reasons for the fall of roman empire
- treatment of chronic pain
- treatment of chronic fatigue syndrome
- treatment of chronic cough